药物信息为RENO-60 Diatrizoate Meglumine Injection USP 60% (Bracco Diagnostics Inc.): DESCRIPTION
- DESCRIPTION
- CLINICAL PHARMACOLOGY
- INDICATIONS
- CONTRAINDICATIONS
- PRECAUTIONS
- Usage In Pregnancy
- ADVERSE REACTIONS
- DOSAGE AND ADMINISTRATION
- HOW SUPPLIED
- 外部链接相关的RENO-60 Diatrizoate Meglumine Injection USP 60% (Bracco Diagnostics Inc.)
Reno-60 is a radiopaque contrast agent supplied as a sterile, aqueous solution for parenteral use. Each mL provides 600 mg diatrizoate meglumine; at manufacture, 3.2 mg sodium citrate buffer and 0.4 mg edetate disodium sequestering agent are added per mL. The pH has been adjusted between 6.0 and 7.7 with meglumine and diatrizoic acid.Each mL of solution also contains approximately 0.91 mg (0.04 mEq) sodium and 282 mg organically bound iodine. At the time of manufacture, the air in the container is replaced by nitrogen.
- Drug Information Provided by National Library of Medicine (NLM).
